Form 4: Simmons First National Corp Executive Brogdon Acquires Restricted Stock Units

Sentiment:

SEC Form 4


James M. Brogdon, President of Simmons First National Corp, reports acquisition of restricted stock units convertible to SFNC common stock.

Summary

  • James M. Brogdon, President of Simmons First National Corp, filed a Form 4 indicating changes in beneficial ownership.
  • On March 4, 2025, Brogdon acquired 24,551 restricted stock units (RSUs) which are convertible to SFNC common stock.
  • These RSUs do not have an exercise price.
  • Following the transaction, Brogdon directly owns 43,284 shares of SFNC Common Stock and 24,551 Restricted Stock Units.
  • The RSUs vest in three tranches: 8,183 on March 4, 2026; 8,184 on March 4, 2027; and 8,184 on March 4, 2028.
  • SFNC shares will be delivered to the reporting person within 30 days of vesting.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing an executive's compensation in the form of stock units. It doesn't inherently indicate positive or negative performance, but rather a routine transaction.

Positives

  • The acquisition of restricted stock units by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock units suggests a multi-year commitment from the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates an award of equity to a key executive, which is a common practice in the financial industry.

Key Dates

DateDescription
03/04/2025Date of earliest transaction: Acquisition of Restricted Stock Units
03/04/2026Vesting date for 8,183 Restricted Stock Units
03/04/2027Vesting date for 8,184 Restricted Stock Units
03/04/2028Vesting date for 8,184 Restricted Stock Units
03/06/2025Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.